First report on the clinical efficacy of chemoimmunotherapy for ultra-rare urachal cancer

First report on the clinical efficacy of chemoimmunotherapy for ultra-rare urachal cancer

Physician-scientists at Kanazawa University have demonstrated, for the first time, the clinical efficacy of chemoimmunotherapy in patients with ultra-rare urachal cancer. Furthermore, their reverse translational research elucidated the mechanism by which the addition of immunotherapy enhances the efficacy of chemotherapy.